Inhibitors of NLRP3 activation for treatment of inflammatory CNS diseases

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1086786

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This project will use novel tool compounds to advance our understanding of inflammatory brain diseases such as Parkinson's disease and Multiple Sclerosis. We will examine the molecular pathways and identify novel means to treat these debilitating diseases. We will then aim to design novel therapeutics which target these pathways.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $1,023,137.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biologically Active Molecules

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

central nervous system (CNS) diseases | drug discovery | inflammation | innate immunity | medicinal chemistry

Related Links